178 related articles for article (PubMed ID: 26467763)
1. Novel STAT1 gain-of-function mutation and suppurative infections.
Giardino G; Somma D; Cirillo E; Ruggiero G; Terrazzano G; Rubino V; Ursini MV; Vairo D; Badolato R; Carsetti R; Leonardi A; Puel A; Pignata C
Pediatr Allergy Immunol; 2016 Mar; 27(2):220-3. PubMed ID: 26467763
[No Abstract] [Full Text] [Related]
2. A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis.
Martinez-Martinez L; Martinez-Saavedra MT; Fuentes-Prior P; Barnadas M; Rubiales MV; Noda J; Badell I; Rodríguez-Gallego C; de la Calle-Martin O
Mol Immunol; 2015 Dec; 68(2 Pt C):597-605. PubMed ID: 26514428
[TBL] [Abstract][Full Text] [Related]
3. Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.
Bloomfield M; Kanderová V; Paračková Z; Vrabcová P; Svatoň M; Froňková E; Fejtková M; Zachová R; Rataj M; Zentsová I; Milota T; Klocperk A; Kalina T; Šedivá A
J Clin Immunol; 2018 Jul; 38(5):589-601. PubMed ID: 29934865
[TBL] [Abstract][Full Text] [Related]
4. Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.
Carey B; Lambourne J; Porter S; Hodgson T
Oral Dis; 2019 Apr; 25(3):684-692. PubMed ID: 29702748
[TBL] [Abstract][Full Text] [Related]
5. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.
Depner M; Fuchs S; Raabe J; Frede N; Glocker C; Doffinger R; Gkrania-Klotsas E; Kumararatne D; Atkinson TP; Schroeder HW; Niehues T; Dückers G; Stray-Pedersen A; Baumann U; Schmidt R; Franco JL; Orrego J; Ben-Shoshan M; McCusker C; Jacob CM; Carneiro-Sampaio M; Devlin LA; Edgar JD; Henderson P; Russell RK; Skytte AB; Seneviratne SL; Wanders J; Stauss H; Meyts I; Moens L; Jesenak M; Kobbe R; Borte S; Borte M; Wright DA; Hagin D; Torgerson TR; Grimbacher B
J Clin Immunol; 2016 Jan; 36(1):73-84. PubMed ID: 26604104
[TBL] [Abstract][Full Text] [Related]
6. Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation.
Higgins E; Al Shehri T; McAleer MA; Conlon N; Feighery C; Lilic D; Irvine AD
J Allergy Clin Immunol; 2015 Feb; 135(2):551-3. PubMed ID: 25662309
[No Abstract] [Full Text] [Related]
7. [A Case of Chronic Mucocutaneous Candidiasis Associated with STAT1 Mutation].
Miura T; Nakazato N; Nagata K; Shinohara N
Nihon Naika Gakkai Zasshi; 2015 Aug; 104(8):1646-51. PubMed ID: 30160848
[No Abstract] [Full Text] [Related]
8. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
Liu L; Okada S; Kong XF; Kreins AY; Cypowyj S; Abhyankar A; Toubiana J; Itan Y; Audry M; Nitschke P; Masson C; Toth B; Flatot J; Migaud M; Chrabieh M; Kochetkov T; Bolze A; Borghesi A; Toulon A; Hiller J; Eyerich S; Eyerich K; Gulácsy V; Chernyshova L; Chernyshov V; Bondarenko A; Grimaldo RM; Blancas-Galicia L; Beas IM; Roesler J; Magdorf K; Engelhard D; Thumerelle C; Burgel PR; Hoernes M; Drexel B; Seger R; Kusuma T; Jansson AF; Sawalle-Belohradsky J; Belohradsky B; Jouanguy E; Bustamante J; Bué M; Karin N; Wildbaum G; Bodemer C; Lortholary O; Fischer A; Blanche S; Al-Muhsen S; Reichenbach J; Kobayashi M; Rosales FE; Lozano CT; Kilic SS; Oleastro M; Etzioni A; Traidl-Hoffmann C; Renner ED; Abel L; Picard C; Maródi L; Boisson-Dupuis S; Puel A; Casanova JL
J Exp Med; 2011 Aug; 208(8):1635-48. PubMed ID: 21727188
[TBL] [Abstract][Full Text] [Related]
9. Recurrent, Severe Aphthous Stomatitis and Mucosal Ulcers as Primary Manifestations of a Novel
Erdős M; Jakobicz E; Soltész B; Tóth B; Bata-Csörgő Z; Maródi L
Front Immunol; 2020; 11():967. PubMed ID: 32547544
[TBL] [Abstract][Full Text] [Related]
10. Recurrent inflammatory aortic aneurysms in chronic mucocutaneous candidiasis with a gain-of-function STAT1 mutation.
Tanimura M; Dohi K; Hirayama M; Sato Y; Sugiura E; Nakajima H; Kanemitsu S; Toyoda H; Yamada N; Masuya M; Imanaka-Yoshida K; Shimpo H; Azuma E; Ito M
Int J Cardiol; 2015 Oct; 196():88-90. PubMed ID: 26080282
[No Abstract] [Full Text] [Related]
11. STAT1 gain-of-function and chronic demodicosis.
Molho-Pessach V; Meltser A; Kamshov A; Ramot Y; Zlotogorski A
Pediatr Dermatol; 2020 Jan; 37(1):153-155. PubMed ID: 31637766
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Disseminated
Chen K; Tan J; Qian S; Wu S; Chen Q
Front Immunol; 2021; 12():682350. PubMed ID: 34421897
[TBL] [Abstract][Full Text] [Related]
13. Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1).
Meesilpavikkai K; Dik WA; Schrijver B; Nagtzaam NMA; Posthumus-van Sluijs SJ; van Hagen PM; Dalm VASH
J Allergy Clin Immunol; 2018 Jul; 142(1):328-330.e2. PubMed ID: 29729898
[No Abstract] [Full Text] [Related]
14. STAT1 gain-of-function compromises skin host defense in the context of IFN-γ signaling.
Niehues H; Rösler B; van der Krieken DA; van Vlijmen-Willems IMJJ; Rodijk-Olthuis D; Peppelman M; Schalkwijk J; van den Bogaard EHJ; Zeeuwen PLJM; van de Veerdonk FL
J Allergy Clin Immunol; 2019 Apr; 143(4):1626-1629.e5. PubMed ID: 30576757
[No Abstract] [Full Text] [Related]
15. Autosomal dominant cases of chronic mucocutaneous candidiasis segregates with mutations of signal transducer and activator of transcription 1, but not of Toll-like receptor 3.
Al Rushood M; McCusker C; Mazer B; Alizadehfar R; Grimbacher B; Depner M; Ben-Shoshan M
J Pediatr; 2013 Jul; 163(1):277-9. PubMed ID: 23541088
[TBL] [Abstract][Full Text] [Related]
16. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
[TBL] [Abstract][Full Text] [Related]
17. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.
van de Veerdonk FL; Plantinga TS; Hoischen A; Smeekens SP; Joosten LA; Gilissen C; Arts P; Rosentul DC; Carmichael AJ; Smits-van der Graaf CA; Kullberg BJ; van der Meer JW; Lilic D; Veltman JA; Netea MG
N Engl J Med; 2011 Jul; 365(1):54-61. PubMed ID: 21714643
[TBL] [Abstract][Full Text] [Related]
18. Clinical heterogeneity of dominant chronic mucocutaneous candidiasis disease: presenting as treatment-resistant candidiasis and chronic lung disease.
Dotta L; Scomodon O; Padoan R; Timpano S; Plebani A; Soresina A; Lougaris V; Concolino D; Nicoletti A; Giardino G; Licari A; Marseglia G; Pignata C; Tamassia N; Facchetti F; Vairo D; Badolato R
Clin Immunol; 2016 Mar; 164():1-9. PubMed ID: 26732859
[TBL] [Abstract][Full Text] [Related]
19. A gain-of-function mutation of STAT1: A novel genetic factor contributing to chronic mucocutaneous candidiasis.
Eslami N; Tavakol M; Mesdaghi M; Gharegozlou M; Casanova JL; Puel A; Okada S; Arshi S; Bemanian MH; Fallahpour M; Molatefi R; Seif F; Zoghi S; Rezaei N; Nabavi M
Acta Microbiol Immunol Hung; 2017 Jun; 64(2):191-201. PubMed ID: 28597685
[TBL] [Abstract][Full Text] [Related]
20. Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis.
Haake K; Wüstefeld T; Merkert S; Lüttge D; Göhring G; Auber B; Baumann U; Lachmann N
Stem Cell Res; 2020 Mar; 43():101713. PubMed ID: 32000109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]